Rheumatic disease and cystic fibrosis (Q33710857)

28 July 2017

1 reference

title

Rheumatic disease and cystic fibrosis (English)

1 reference

28 July 2017

0 references

1 reference

1 reference

Merkel PA

1

1 reference

28 July 2017

1 August 1999

1 reference

28 July 2017

Arthritis & Rheumatology

1 reference

28 July 2017

42

1 reference

28 July 2017

8

1 reference

28 July 2017

1563-1571

1 reference

Episodic arthritis in children with cystic fibrosis

28 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Arthritis in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

The musculoskeletal manifestations of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Episodic arthritis in cystic fibrosis: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

The arthropathy of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Episodic arthritis in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Cystic fibrosis and episodic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Absence of an association between HLA typing in cystic fibrosis arthritis and hypertrophic osteoarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Identification of the cystic fibrosis gene: genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Spectrum of mutations in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

CFTR expression and organ damage in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Cystic fibrosis and hypertrophic osteoarthropathy in children. Report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Hypertrophic osteoarthropathy in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Bone changes associated with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Osteoporosis in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Osteopenia in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Bone mineral density and body composition in adult patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Kyphosis and fractures in children and young adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Vitamin D and parathyroid hormone and bone mineralisation in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Cutaneous necrotizing venulitis in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Hypergammaglobulinemic purpura in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Pulmonary infection and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Immunologic aspects of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Antineutrophil cytoplasmic antibodies in the classification of vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Amyloidosis complicating cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Copulsatile release of thyrotropin and prolactin in normal and hypothyroid subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Amyloid goitre and hypothyroidism secondary to cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Safety of ciprofloxacin in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Cystic fibrosis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Sarcoidosis in two patients with cystic fibrosis: a fortuitous association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Sarcoidosis in an adult with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Sarcoid arthropathy in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Effect of high-dose ibuprofen in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Osteoporosis in lung transplantation candidates with end-stage pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Arthropathy Secondary to Ciprofloxacin in an Adult Cystic Fibrosis Patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Episodic arthritis in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Arthritis in childhood cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Cystic fibrosis arthritis. A report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Bilateral hip replacements in a man with cystic fibrosis and episodic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Hypogammaglobulinemia in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Psoriatic or cystic fibrosis arthropathy? Difficulty with diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Cross-reactive epitope with Klebsiella pneumoniae nitrogenase in articular tissue of HLA-B27+ patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Correlation between genotype and phenotype in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

A Cystic Fibrosis Mutation Associated with Mild Lung Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

IMMUNOFLUORESCENT TECHNIQUES IN BACTERIAL MENINGITIS. IDENTIFICATION OF NEISSERIA MENINGITIDIS AND HEMOPHILUS INFLUENZAE

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Pulmonary hypertrophic osteoarthropathy in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Hypertrophic pulmonary osteoarthropathy in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Evaluation of pulmonary hypertrophic osteoarthropathy in cystic fibrosis. A comprehensive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Vitamin D metabolites in adolescents and young adults with cystic fibrosis: effects of sun and season

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Low serum bone gamma-carboxyglutamic acid protein concentrations in patients with cystic fibrosis: correlation with hormonal parameters and bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Bone density in children and adolescents with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Body composition analysis by dual-energy x-ray absorptiometry in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Osteopenia in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Cutaneous necrotizing venulitis in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Cutaneous manifestations of cystic fibrosis: possible role of cryoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Endocrine pancreas in cystic fibrosis: An immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Specific toxicologic aspects of the quinolones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Cystic fibrosis and drug-induced arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Role of the new quinolones in pediatric practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

Tolerance and safety of ciprofloxacin in paediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199908%2942%3A8%3C1563%3A%3AAID-ANR1%3E3.0.CO%3B2-H

10.1002/1529-0131(199908)42:8<1563::AID-ANR1>3.0.CO;2-H

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10446852